Among these high-risk genes, those dysregulated in more than one cell type, such as CNTNAP2 and SORL1 (Fig. 4G), may represent potential targets to defer the onset of cognitive decline and neurodegenerative diseases in the elderly. This evidence concerns the gene CNTNAP2 and neurodegenerative disease.